% | $
Quotes you view appear here for quick access.

InterMune, AŞ Message Board

  • tradingexpert4me tradingexpert4me Aug 24, 2013 2:51 PM Flag

    Richly priced here in the mid teens. Don't expect any buyout until and "IF" the FDA approves. A partner

    is possible, but one would of thought there would be one by now, so again not likely ahead of FDA. Europe is moving along, but needs to ramp up more quickly. Not the insiders fault, it's just a longer process than many anticipated.

    Still working on my DD and curious if InterMune receives any royalties from Japan, where drug has been approved. Did read anything on it in last report transcript. With the 9-3 & 7-5 favorable panel votes in 2010, followed by non FDA approval, I'm just glad I came along after the carnage.

    I made a killing in DNDN over 13 months, buying 7.30 per share and selling day of FDA approval. I believe InterMune will receive FDA approval on it's second PHASE III in 2014. Hoping for shares to pullback to 9-10 range, but if this decides to continue back higher, I'll start scaling in my long position.


    SortNewest  |  Oldest  |  Most Replied Expand all replies